Form 4: Angiodynamics Executive Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


Chad Thomas Campbell, SVP/GM, Vascular Access of Angiodynamics Inc, reported multiple transactions in common stock on July 16, 2026.

Summary

  • Tax/exercise-price withholding: disposed of 2,367 Common Stock at $14.14 ($33,469) on July 16, 2026; holds 89,930 after (Direct).
  • Tax/exercise-price withholding: disposed of 1,112 Common Stock at $13.51 ($15,023) on July 17, 2026; holds 88,818 after (Direct).
  • Tax/exercise-price withholding: disposed of 359 Common Stock at $13.71 ($4,922) on July 20, 2026; holds 88,459 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Chad Thomas Campbell — Officer (SVP/GM, Vascular Access)

DateTransactionSecuritySharesPriceValueHeld After
2026-07-16Tax/exercise-price withholdingCommon Stock2,367$14$33.5K89,930
2026-07-17Tax/exercise-price withholdingCommon Stock1,112$14$15.0K88,818
2026-07-20Tax/exercise-price withholdingCommon Stock359$14$4.9K88,459

Key Dates

DateDescription
2026-07-16Tax/exercise-price withholding (2,367 shares)
2026-07-17Tax/exercise-price withholding (1,112 shares)
2026-07-20Tax/exercise-price withholding (359 shares)

Keywords

insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Chad Thomas Campbell

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.